Preterm birth is a major determinant of neonatal mortality and morbidity, affecting approximately one-third of preterm births as a result of prelabor rupturing of membranes. Infection and inflammation have strong causal links to preterm delivery, resulting in the activation of nuclear factor-kappaB (NFKB) and its downstream targets. Human sirtuin (SIRT) 6, which has ADPribosyl transferase and deacetylase activity, exhibits antiinflammatory actions. The aims of this study were to determine the effect of 1) human preterm labor on SIRT6 expression in human gestational tissue and 2) the effect in primary amnion cells of SIRT6 inhibition, using small interfering RNA (siRNA) on prolabor mediators. To determine the effect of human preterm labor on SIRT6 expression, human fetal membranes were collected from women at preterm at the time of Cesarean section (no labor; n ¼ 9) and from women after spontaneous labor and delivery (n ¼ 9). SIRT6 mRNA and protein expression were significantly lower in fetal membranes after spontaneous preterm labor. Transfection of primary amnion cells with SIRT6 siRNA was associated with an increase in IL-1beta-induced proinflammatory cytokine gene expression and release (IL6, IL8, TNF [TNF-alpha]), cyclooxygenase ([COX]-2; official symbol PTGS2) expression and subsequent prostaglandin (PGE 2 and PGF 2alpha ) release, and MMP9 gene expression and release of pro-MMP9. To determine whether SIRT6 affects NFKB transcriptional activity, primary amnion cells were transfected with NFKB tagged with luciferase and stimulated with IL1B. As expected, IL1B induced NFKB transcriptional activity. However, when cells were also cotransfected with a vector expressing SIRT6, there was a decrease in NFKB transcriptional activity. In conclusion, SIRT6 plays a role in regulating the terminal effector pathways of human labor and delivery via the NFKB pathway.
INTRODUCTION
Preterm birth (i.e., less than 37 wk gestation) with its attendant morbidity and mortality remains amongst the most significant health care issues in the developed world; global estimates of preterm birth in 2005 were 9.6% of all births [1] . Prematurity is the leading direct cause of early neonatal death, responsible for 29% or approximately one million annual neonatal deaths [2] . Preterm prelabor rupture of membranes (pPROM) represents 20%-25% of preterm births, with the remaining 30%-35% resulting from intervention for maternal or fetal problems. Idiopathic preterm labor (with intact membranes) accounts for 40%-50% of preterm births [3] . A strong etiological factor of preterm birth is infection and inflammation, which are involved in up to 40% of cases [4] . The survivors of preterm birth have greatly increased rates of long-term disabilities, including cerebral palsy, intellectual handicap, neurocognitive disorders, and other sensorineural dysfunctions [5] . The substantial medical and social consequences extend beyond childhood [6] . The process of human parturition remains incompletely understood, resulting in an inability to prevent the birth of extremely small preterm babies [7] . To develop appropriate, efficacious prevention strategies and interventions to improve survival of neonates born prematurely, a better understanding of the mechanisms that control human labor is required.
For a successful outcome to labor and delivery at term, certain proximal events result in an increase in the availability and bioactivity of phospholipid mediators, such as prostaglandins and cytokines [8] [9] [10] [11] [12] . These effector pathways include the formation of uterotonic agents and contraction-associated proteins, extracellular matrix (ECM) remodeling of the cervix, and rupture of fetal membranes. A number of transcriptional regulators have been identified that coordinate the timely expression of these terminal effector pathways, including the proinflammatory transcription factor nuclear factor-jB (NFKB) [13] [14] [15] [16] [17] [18] .
There is now increasing evidence that sirtuin (SIRT) transcription factors regulate NFKB and its target genes [19] [20] [21] . We have previously established the presence and functional role of SIRT1 and SIRT2 in human gestational tissues [22] . Importantly, the in vitro activation of SIRT1 inhibits the mediators involved in the effector pathways of human labor and delivery. Recent studies have also revealed that SIRT6 possesses anti-inflammatory properties [23] [24] [25] . SIRT6 is an NAD þ -dependent, histone H3 lysine 9 (H3K9) deacetylase, modulating telomeric chromatin and gene expression [26, 27] . SIRT6-deficient mice display a degenerative phenotype with features of premature aging, leading to death at 4-5 wk of age [28] . These mice also show increased expression of NFKB-dependent genes in a number of tissues [27] .
In essence, SIRT6 is considered to have anti-inflammatory functions. As the process of human labor displays hallmarks of an inflammatory response, SIRT6 may play a role in this process. In this study, we will determine the effect of spontaneous preterm labor in fetal membranes on SIRT6 expression, where the mRNA and protein expression will be quantified using quantitative real-time-PCR (qRT-PCR) and Western blot analysis, respectively. The cellular distribution of SIRT6 in human fetal membranes will be determined by immunohistochemistry. To determine if SIRT6 regulates proinflammatory and prolabor mediators, we will investigate the effect of SIRT6 inhibition and overexpression in primary amnion cells.
MATERIALS AND METHODS

Sample Collection
Human placenta and attached fetal membranes were obtained (with the Research Ethics Committee of Mercy Health and Aged Care approval) from consenting women who delivered at preterm (,37 wk gestation). The women exhibited no clinical signs of infection. Groups were 1) preterm no labor: Cesarean section with no labor (n ¼ 9); and 2) preterm labor: after spontaneous labor and normal vaginal delivery (n ¼ 9). The clinical details of the patients are detailed in Table 1 . All the placentas collected from preterm gestations were swabbed for microbiological culture investigations and histopathological examination. Patients with chorioamnionitis were excluded from the analyses. Women with preeclampsia, preexisting diabetes, asthma, multiple pregnancies, and fetuses with chromosomal abnormalities were also excluded. Indications for preterm delivery (in the absence of labor) were placenta praevia, placental abruption, antepartum hemorrhage, or Rhesus isoimmunization.
Tissues were obtained within 10 min of delivery. To ensure no sampling error bias, fetal membranes from both the nonlaboring and after labor preterm groups were obtained 2 cm from the periplacental edge. Tissues were washed extensively with PBS, and immediately snap frozen in liquid nitrogen and immediately stored at À808C. The effect of spontaneous preterm labor on SIRT6 mRNA and nuclear protein expression was determined by qRT-PCR and Western blot analysis, respectively (as detailed below).
Immunohistochemistry
To determine the localization of SIRT6 in fetal membranes, immunohistochemistry was performed as described previously [29] . For these studies, fetal membranes were obtained from women who delivered healthy, singleton infants at term (.37 wk gestation) undergoing elective Cesarean section in the absence of labor. Fetal membranes, taken 2 cm form the periplacental edge, were fixed and paraffin embedded for immunohistochemical analysis. Rabbit polyclonal anti-SIRT6 (S4197; Sigma) was used at 2.5 lg/ml in 1% (wt/vol) bovine serum albumin in 50 mM Tris-Cl, pH 7.5, and 150 mM NaCl (TBS). Negative control slides, where primary antibody was replaced with normal rabbit immunoglobulin G serum were also included.
Tissue Explant Culture
Tissue explants were performed to determine the effect of lipopolysaccharide (LPS) on SIRT6 expression (n ¼ 4 patients). For these studies, fetal membranes were obtained from women who delivered healthy, singleton infants at term (.37 wk gestation) undergoing elective Cesarean section in the absence of labor. Combined fetal membranes obtained 2 cm from the periplacental edge were placed in RPMI-1640 medium at 378C in a humidified atmosphere of 8% O 2 and 5% CO 2 for 1 h. Tissues were blotted dry on sterile filter paper and transferred to 24-well tissue culture plates (200 mg wet weight/ well). The tissues were incubated, in duplicate, in 2 ml RMPI-1640 containing 100 units (U)/ml penicillin G and 100 lg/ml streptomycin. Tissues were incubated in the absence or presence of 10 lg/ml LPS. After 20 h incubation, tissue was collected and stored at À808C until assessed for SIRT6 mRNA and nuclear protein expression as detailed below.
Gene Silencing of SIRT6 with Small Interfering RNA in Primary Amnion Cells Primary amnion cells were used to investigate the effect of small interfering RNA (siRNA)-mediated gene silencing of SIRT6 on prolabor mediators. For these studies, reflected amnion was obtained from women who delivered healthy, singleton infants at term (.37 wk gestation) undergoing elective Cesarean section in the absence of labor. Primary amnion epithelial cells were prepared as previously described [30] and incubated in Dulbecco modified Eagle medium/ Ham F12 (DMEM/F12) enriched with 10% fetal calf serum (FCS), 100 U/ml penicillin G, and 100 lg/ml streptomycin. Cells at approximately 50% confluence were transfected using SilenceMag reagent according to manufacturer's guidelines (Oz Biosciences). Cells were transfected with 100 nM SIRT6 (Ambion) or nonspecific (NS) siRNA (Ambion) in DMEM/F-12 for 72 h. The medium was then replaced with DMEM/F-12 with 2% heat-inactivated FCS, with or without 1 ng/ml IL-1beta (IL1B), and the cells were incubated at 378C for an additional 24 h. Cells were collected and stored at À808C until assayed for mRNA expression by qRT-PCR and protein expression by Western blots as detailed below. Media was collected and stored at À808C until assayed for cytokine, prostaglandin, and MMP release as detailed below. Experiments were performed from amnion obtained from six patients.
Luciferase Assay
A luciferase assay was utilized to determine possible interactions between SIRT6 and NFKB. For these studies, transfection-ready SIRT6 human cDNA clone, vector pcMV6-XL5 (Origene) was used; an empty vector was used as the control plasmid. Primary amnion cells, prepared as described above, at approximately 70% confluence were transfected using X-tremeGene HP DNA Transfection Reagent according to manufacturer's guidelines. Cells were transfected with 0.25 lg pNFKB-luc (Qiagen) plus either 0.5 lg empty pcMV6-XL5 plasmid or 0.5 lg SIRT6 plasmid for 48 h. The medium was then replaced with DMEM/F-12 with 2% heat-inactivated FCS, with or without 1 ng/ ml IL1B, and the cells incubated at 378C for an additional 24 h. The cells were harvested in lysis buffer, and luminescence activity was measured using the Dual-Glo Luciferase Assay kit (Promega) as instructed. The results are expressed as a ratio of luciferase activity of NFKB reporter plus empty pCMV6 vector group, which was set at 1. The experiments were performed from amnion obtained from four patients.
Cytokine and Prostaglandin Immunoassays
The release of IL6 and IL8 was performed by sandwich ELISA according to the manufacturer's instructions (Invitrogen). The release of PGE 2 and PGF 2a into the incubation medium was assayed using a commercially available competitive enzyme immunoassay kit according to the manufacturer's specifications (Kookaburra Kits; Sapphire Bioscience).
Gelatin Zymography
Assessment of enzymes of ECM weakening and rupture (i.e., MMP9) was performed by gelatin zymography as previously described [15, 31] . Gels were LIM ET AL.
viewed and analyzed using the Chemi-Doc system (Bio-Rad). Quantitative analysis of the relative density was performed using Quantity One 4.2.1 image analysis software (Bio-Rad). Data were corrected for background, and the fold change was calculated relative to IL1B-stimulated NS siRNA transfected cells, which was set at 1.
Western Blot Analysis
To determine SIRT6 protein expression in fresh tissue and tissue explants, nuclear protein was extracted as described previously [13] ; for primary amnion cells, total protein was extracted with RIPA lysis buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% Igepal, 0.1% SDS, 0.25% Na deoxycholate, 1 mM ethylenediaminetetraacetic acid, pH 7.4). Western blot analysis was performed as previously described [30] . Blots were incubated with 1 lg/ml rabbit anti-SIRT6 (Sigma) diluted in blocking buffer (5% skim milk in TBS plus 0.05% Tween) for 16 h at 48C. Membranes were viewed and analyzed using the Chemi-Doc system (Bio-Rad). Quantitative analysis of the relative density of the bands in the Western blots was performed using Quantity One 4.2.1 image analysis software (Bio-Rad). For SIRT6, two isoforms were present, and quantification was performed on both bands. Data were corrected for background and normalized to b-actin or Ponceau S staining (for nuclear protein [32] ).
RNA Extraction and qRT-PCR
Total RNA from tissues and cells was extracted using TRI reagent according to manufacturer's instructions (Sigma-Aldrich). The quantitation and estimation of RNA purity was assessed using a NanoDrop spectrophotometer (ThermoFisher Scientific). RNA was converted to cDNA using the SuperScript VILO cDNA synthesis kit (Invitrogen) according to the manufacturer's instructions. The cDNA was diluted 50-fold, and 4 ll of cDNA was used to perform qRT-PCR using Sensimix Plus SYBR green (Quantace) and 100 nM of prevalidated primers: SIRT6 (QT00056812), GAPDH (QT01192646), IL6 (QT00083720), IL8 (QT00000322), TNF (QT01079561), PTGS1 (COX-1) (QT00210280), PTGS2 (COX-2) (QT00040586), MMP2 (QT00088396), and MMP9 (QT00040040) (Qiagen). Average gene C T values were normalized to the average GAPDH C T values of the same cDNA sample. RNA without reverse transcriptase during cDNA synthesis as well as PCR reactions using water instead of template showed no amplification. Fold differences were determined using the comparative C T method, and the data was expressed as the ratio compared to controls.
Statistical Analysis
Statistical analysis was performed using a commercially available statistical software package (Statgraphics Plus version 3.1; Statistical Graphics Corp.). Two-sample comparisons were analyzed using either a paired-sample test or Student t-test. For all other analyses, one-way ANOVA (using logarithmic series distribution correction to discriminate among the means) was performed, and the homogeneity of data was assessed by the Bartlett test. When significant, the data were logarithmically transformed before further analysis. Statistical significance was ascribed to P , 0.05. Data was expressed as mean 6 standard error of the mean (SEM).
RESULTS
Immunohistochemical Localization of SIRT6 Expression in Term Fetal Membranes
Immunohistochemistry was used to determine the cellular localization of SIRT6 in human fetal membranes (amnion and choriodecidua). Fetal membranes exhibited strong SIRT6 staining (Fig. 1A) . There was positive SIRT6 staining in the amnion epithelium, which was predominantly nuclear. Similarly, mostly nuclear SIRT6 staining was detected in the chorionic trophoblasts. Decidua also exhibited strong nuclear SIRT6 staining. No staining was observed in the negative control for fetal membranes (Fig. 1B) .
Effect of Spontaneous Preterm Labor on SIRT6 Expression
We examined SIRT6 expression in fetal membranes from women with 1) preterm no labor: Cesarean section with no labor (n ¼ 9); and 2) preterm labor: after spontaneous labor and normal vaginal delivery (n ¼ 9). Baseline characteristics for these populations are outlined in Table 1 . Women with preterm deliveries were matched for maternal age, body mass index (BMI), gravidity, parity and gestational age. Fetal birth weight was significantly higher in the preterm labor cohort compared to preterm no labor.
SIRT6 mRNA expression is demonstrated in Figure 2A . SIRT6 mRNA expression was significantly lower after spontaneous labor in preterm fetal membranes. Western blots were used to examine the effect of human preterm labor on SIRT6 nuclear protein expression. As demonstrated in Figure  2B , two bands were detected corresponding to SIRT6 (two isoforms produced by alternate splicing). When compared to fetal membranes from the nonlaboring groups, nuclear SIRT6 protein expression was significantly lower after preterm spontaneous labor and delivery.
Given that infection is the biggest etiological factor for preterm birth, we next sought to determine the effect of the endotoxin LPS on SIRT6 expression. Fetal membranes were incubated with or without 10 lg/ml LPS for 20 h, and SIRT6 mRNA and nuclear protein expression were assessed by qRT-PCR and Western blot analysis, respectively. When compared to basal, the addition of LPS significantly decreased SIRT6 mRNA expression (Fig. 2C) . Similarly, LPS decreased nuclear SIRT6 protein expression in fetal membranes. Representative Western blot images and quantitation for SIRT6 are shown in Figure 2D . 
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Effect of SIRT6 Knockdown in Primary Amnion Cells by siRNA on the Expression of Prolabor Mediators
Having shown that preterm labor and LPS down-regulates SIRT6 expression, we next sought to determine the effect of SIRT6 knockdown on the expression of mediators that are associated with human preterm labor. To do this, primary amnion cells were transfected with and without SIRT6 siRNA and NS siRNA (n ¼ 6 patients). The efficacy of transfection was analyzed by qRT-PCR and Western blot analysis.
FIG. 2. Effect of human preterm labor and LPS on SIRT6 expression in fetal membranes. A, B)
Fetal membranes were obtained from preterm nonlaboring women (n ¼ 9) and women after spontaneous preterm labor and delivery (n ¼ 9). A) SIRT6 gene expression was normalized to GAPDH mRNA expression, and the fold change was calculated relative to no labor. Data is displayed as mean 6 SEM. *P , 0.05 versus no labor (Student t-test). B) Nuclear protein was extracted and SIRT6 expression analyzed by Western blots. SIRT6 protein expression is displayed as SIRT6 expression normalized to loading control. *P , 0.05 versus no labor (Student t-test). Representative Western blot of four patients per group is shown. C, D) Human fetal membranes were incubated in the absence (basal) or presence of 10 lg/ml LPS for 20 h (n ¼ 4 patients). C) SIRT6 gene expression was normalized to GAPDH mRNA expression, and the fold change was calculated relative to basal expression. Data is displayed as mean 6 SEM. *P , 0.05 versus basal (paired sample comparison). D) Nuclear protein was extracted and SIRT6 expression analyzed by Western blots. SIRT6 expression was normalized to loading control, and the fold change was calculated relative to basal expression. Data is displayed as mean 6 SEM. *P , 0.05 versus basal (paired sample comparison).
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Compared to NS siRNA transfected primary amnion cells, transfection with SIRT6 siRNA resulted in a significant decrease in SIRT6 mRNA (Fig. 3A) and protein expression (Fig. 3B ). There was, however, no effect of SIRT6 siRNA on b-actin protein expression (Fig. 3B) .
Primary amnion cells were transfected with NS or SIRT6 siRNA as detailed above. Seventy-two hours after transfection, cells were treated with IL1B for 24 h (n ¼ 6 patients). The effect of SIRT6 siRNA on IL1B-induced proinflammatory and prolabor gene expression and release from primary amnion cells is demonstrated in Figures 4-6 .
The effect of SIRT6 siRNA on IL1B-induced proinflammatory cytokine gene expression and release from primary amnion cells is demonstrated in Figure 4 . Compared to basal NS siRNA, IL1B treatment of NS siRNA significantly increased IL6, IL8, and TNF mRNA expression (Fig. 4A ) and IL6 and IL8 release (Fig. 4B) . IL6, IL8, and TNF mRNA expression was significantly increased in SIRT6 deficient cells.
The effect of SIRT6 inhibition on the COX-prostaglandin pathway is described in Figure 5 . As expected, treatment of primary amnion cells with IL1B significantly increased PTGS2 (COX-2) expression (Fig. 5A ) and the concentrations PGF 2a in the media (Fig. 5B) . The loss of SIRT6 was associated with statistically higher PTGS2 mRNA, PGE 2 , and PGF 2a release. There was no effect of IL1B or SIRT6 siRNA on PTGS1 mRNA expression (data not shown).
Figures 6A shows that in NS siRNA transfected cells, IL1B induced an increase in MMP9 mRNA expression. Likewise, by gelatin zymography, secretory pro-MMP9 activity was also significantly higher with IL1B treatment (Fig. 6B) . When SIRT6 was knocked out, there was statistically higher MMP9 mRNA and pro-MMP9 activity. There was no effect of IL1B or SIRT6 siRNA on MMP2 mRNA expression or secretory pro-MMP2 activity (data not shown).
SIRT6 Represses Prolabor Mediators Through NFKB
Studies in nongestational tissues have shown that SIRT6 represses inflammation by inhibiting NFKB activity [27] . There is now much data to show that NFKB plays a central role for in the regulation of proinflammatory and prolabor mediators in fetal membranes [16] [17] [18] 22] . Thus, we hypothesized that SIRT6 may also regulate prolabor mediators in primary amnion cells through NFKB. We addressed this by determining the effect of SIRT6 overexpression on NFKB transcriptional activity. We transfected primary amnion cells with an NFKB-luc reporter in the absence (control vector pcDNA3.1 vector) or presence of SIRT6 expression vector for 48 h. Cells were then stimulated with 1 ng/ml IL1B for an additional 24 h, and NFKB transcriptional activity was assessed by luminescence. As shown in Figure 7A , in amnion cells expressing the NFKB-luc reporter, treatment with IL1B significantly increased luciferase activity; overexpression of SIRT6 inhibited NFKB-mediated luciferase reporter expression. Western blot analysis confirmed the overexpression of SIRT6 (Fig. 7B) .
DISCUSSION
In this study, we report, for the first time, the localization and expression of SIRT6 in term fetal membranes and   FIG. 3 . Efficiency of SIRT6 siRNA transfection. Human primary amnion cells were transfected with or without 100 nM SIRT6 or NS siRNA (n ¼ 6 patients) for 96 h. A) SIRT6 mRNA expression was normalized to GAPDH mRNA expression, and the fold change was calculated relative to NS siRNA transfected cells. Data is displayed as mean 6 SEM. *P , 0.05 versus NS siRNA (paired sample comparison). B) SIRT6 protein expression, analyzed by Western blots, was normalized with respect to b-actin, and the fold change was calculated relative to NS siRNA transfected cells. Data is displayed as mean 6 SEM. *P , 0.05 versus NS siRNA (paired samples comparison).
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demonstrate a novel anti-inflammatory role for SIRT6 in human pregnancy. Lower mRNA and protein expression of SIRT6 was found in fetal membranes obtained after spontaneous preterm labor and in the presence of LPS. The effect of SIRT6 knockdown in cultured primary amnion cells was an augmentation of IL1B-induced proinflammatory and prolabor mediators. These effects appear to be mediated by NFKB. Collectively, our data shows that the loss of SIRT6 may play a role in initiating the processes of preterm labor and delivery.
SIRT6 was localized in the amnion epithelial cells and the chorionic trophoblasts of the fetal membranes, and lower expression was found after spontaneous preterm labor and delivery. In the preterm labor group, only two of the samples had pPROM, and we could not determine what affect membrane rupture has on SIRT6 expression. At term, a focal area of the human fetal membranes overlying the cervical os, the supracervical site, exhibits morphological changes that has been shown to encompass the site of rupture [33] . We and others have shown that in term nonlaboring supracervical fetal membranes, morphological and biochemical differences exist when compared to distal aspects of the fetal membranes [33] [34] [35] . To date, there are no reports that have studied regional differences in fetal membranes from preterm fetal membranes. In this study, to ensure no sample error bias, all preterm samples were taken from the same location close to the periplacental edge.
Intrauterine infection and inflammation have firm causal links with spontaneous preterm labor and pPROM [36, 37] . Of note, we found that SIRT6 expression was also lower in fetal membranes treated with bacterial endotoxin LPS, suggesting that SIRT6 may play a functional role in preterm labor. Pregnancies affected by infection are characterized by elevated levels of proinflammatory cytokines in the amniotic fluid, myometrium, fetal membranes, and maternal serum, notably IL1B, IL6, IL8, and TNF [36] . These cytokines can induce the production of prostaglandins [38] and MMPs, which are able to degrade the main ECM components of the membranes [39] . Rupture of membranes is necessary for the delivery process, at   FIG. 4 . Effect of SIRT6 knockdown on proinflammatory cytokines. Human primary amnion cells were transfected with or without 100 nM SIRT6 or NS siRNA for 72 h, then treated with IL1B for an additional 24 h (n ¼ 6 patients). A) Gene expression for IL6, IL8, and TNF was analyzed by qRT-PCR. Cytokine mRNA expression was normalized to GAPDH mRNA expression, and the fold change was calculated relative to IL1B-stimulated NS siRNA transfected cells. Data is displayed as mean 6 SEM (one-way ANOVA). *P , 0.05 versus IL1B-stimulated NS siRNA transfected cells. B) The incubation medium was assayed for concentration of IL6 and IL8 release by ELISA. Each bar represents mean concentration 6 SEM (one-way ANOVA). *P , 0.05 versus IL1B-stimulated NS siRNA transfected cells.
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both term and preterm, and the events involved in this process are a consequence of programmed weakening; this process involves cytokines and the activation of MMPs and prostaglandins [33] . Our results show that in amnion cells treated with IL1B, SIRT6 inhibition increased the expression of proinflammatory cytokines IL6, IL8, and TNF, increased prostaglandin production, and increased MMP9 expression.
The anti-inflammatory effects of SIRT6 are a result of its histone deacetylase activity, which thereby represses target gene transcription [26] . The most notable target of SIRT6 is the NFKB promoter [27] . The NFKB family of transcription factors controls the activity of genes involved in apoptosis, inflammation, and immunity (reviewed by Hayden and Ghosh [40] ). SIRT6 regulates NFKB-dependent genes through its interaction with the RelA subunit [27] ; recruitment to chromatin at the promoters of RelA represses NFKB target gene expression by deacetylating histone H3K9 [26] . In human gestational tissues, NFKB activation regulates proinflammatory cytokines IL6, IL8, and TNF as well as PTGS2, the resultant prostaglandins, and MMP9, all of which are critical for the initiation of labor [13, [16] [17] [18] 22] . In this study using a luciferase assay, NFKB transcriptional activity was significantly reduced in cells that also overexpresssed SIRT6.
Collectively, this suggests that in the presence of SIRT6, primary amnion cells display hypoactive NFKB, leading to decreased transcription of proinflammatory and prolabor genes. Likewise, and in support of our studies, there is increased expression of NFKB and its target genes in a number of tissues of SIRT6-deficient mice [27] and cells [25] .
Despite improvements in the care of premature infants in recent years, preterm birth is the most prominent cause of neonatal mortality and morbidity [3] . There is an inability to successfully suppress preterm labor that leads to very small and sick babies. Tocolytic drugs are currently used to pharmacologically manage preterm labor with intact membranes. They are intended to stop uterine contractions or maintain uterine quiescence in order to prolong pregnancy to term or long enough to increase or improve fetal development. However, as reviewed by Berkman et al. [41] , there are maternal risks and insufficient data showing benefits to neonatal morbidity and mortality. Additionally, the use of tocolytics in women with pPROM is controversial; tocolytics are usually conservatively administered in the absence of labor, infection, or fetal distress. But pPROM is strongly associated with infection, and the use of tocolytic therapy has not been proven to be beneficial with regards to maternal and infant morbidity and mortality for FIG. 5 . Effect of SIRT6 knockdown on PTGS2-prostaglandin pathway. Human primary amnion cells were transfected with or without 100 nM SIRT6 or NS siRNA for 72 h, then treated with IL1B for an additional 24 h (n ¼ 6 patients). A) PTGS2 gene expression was normalized to GAPDH mRNA expression, and the fold change was calculated relative to IL1B-stimulated NS siRNA transfected cells. Data is displayed as mean 6 SEM (one-way ANOVA). *P , 0.05 versus IL1B-stimulated NS siRNA transfected cells. B) The incubation medium was assayed for concentration of PGE 2 and PGF 2a release by enzyme immunoassay. Each bar represents the mean concentration 6 SEM (one-way ANOVA). *P , 0.05 versus IL1B-stimulated NS siRNA transfected cells.
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women with pPROM [42] . Research into the mechanisms of labor would aid in developing therapies for preterm labor. Our studies have shown that SIRT6 is involved in human preterm labor and represents an important point of intervention; the activation of SIRT6 could effectively suppress labor mediators that lead to the rupturing of membranes. However, whether or not activation of SIRT6 can prevent infection-induced preterm labor in vivo has yet to be established.
Our data demonstrates that SIRT6 regulates prolabor mediators in fetal membranes. We report a decrease in SIRT6 expression in the fetal membranes from women who have undergone preterm labor. SIRT6 silencing by siRNA showed an augmentation of the effects of IL1B-induced proinflammatory and prolabor mediators. Figure 8 depicts our working model of how SIRT6 regulates preterm labor through the rupturing of membranes. We hypothesize that during preterm labor (triggered by infection), SIRT6 expression is downregulated, leading to increased activity of NFKB and its target products, namely proinflammatory cytokines, prostaglandins, and MMP9 expression. The up-regulation of these prolabor mediators leads to fetal membrane rupture, which then Promoter activity is expressed as a ratio of luciferase activity of NFKB reporter plus empty pCMV6 vector group. Each bar represents the mean 6 SEM. *P , 0.05 versus cells transfected with NFKB reporter plus empty pCMV6 vector (one-way ANOVA). B) Western blot analysis confirmed overexpression of SIRT6 using this plasmid.
FIG. 6. Effect of SIRT6 knockdown on MMP9 expression and activity. Human primary amnion cells were transfected with or without 100 nM SIRT6 or NS siRNA for 72 h, then treated with IL1B for an additional 24 h (n ¼ 6 patients). A) MMP9 gene expression was normalized to GAPDH mRNA expression, and the fold change was calculated relative to IL1B-stimulated NS siRNA transfected cells. Data is displayed as mean 6 SEM (one-way ANOVA). *P , 0.05 versus IL1B-stimulated NS siRNA transfected cells. B) The incubation medium was assayed for MMP9 activity by gelatin zymography. Zymography from one patient is shown. Active MMP9 levels were confirmed by densitometry, and the fold change was calculated relative to IL1B-stimulated NS siRNA transfected cells. Each bar represents the mean 6 SEM (one-way ANOVA). *P , 0.05 versus IL1B-stimulated NS siRNA transfected cells.
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eventually leads to labor and delivery. Whether SIRT6 regulates other terminal events of labor (i.e., cervical ripening and uterine contractions) is subject to further investigation. The effects of SIRT6 overexpression rather excitingly suggests that activation of SIRT6 could be useful in the management and treatment of preterm labor, a potential that certainly warrants further study.
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